Skip to main content
Clinical Trials/NCT04557540
NCT04557540
Completed
Not Applicable

Comparison of Intermittent Fasting With Continuous Caloric Reduction in Black Adults of Faith

Roswell Park Cancer Institute1 site in 1 country44 target enrollmentSeptember 25, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Obesity-Related Malignant Neoplasm
Sponsor
Roswell Park Cancer Institute
Enrollment
44
Locations
1
Primary Endpoint
Change in heart rate
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This trial compares the effect of intermittent fasting versus continuous caloric reduction for the reduction of body weight in Black adults of faith. Intermittent fasting and continuous caloric reduction interventions may help Black adults of faith lose weight, improve their health, and help reduce cancer risk.

Detailed Description

PRIMARY OBJECTIVES: I. Partner with the First Ladies of Western New York (FLOW) to engage 10 community stakeholders from Black churches in the Roswell Park Catchment area in a four-stage process involving information gathering, discussion groups, and mock intervention delivery to create Fasting WORD for Black adults of faith. II. Implement and determine the initial comparative effectiveness of Fasting WORD with The WORD to reduce body weight, and biomarkers of obesity, inflammation, insulin, and insulin resistance. SECONDARY OBJECTIVES: I. Examine the interventions' effects on diet and physical activity. II. Examine participants' adherence and satisfaction with both interventions. OUTLINE: Participants are randomized to 1 of 2 arms. ARM I: Participants receive the Fasting WORD intermittent fasting weight loss intervention consisting of 16 small-group lessons over 1.5 hours each once a week (QW) for 2 months and then once every 2 weeks (Q2W) for 4 months. ARM II: Participants receive The WORD continuous energy restriction (CER) weight loss intervention consisting of 16 small-group lessons over 1.5 hours each QW for 2 months and then Q2W for 4 months. After completion of study, participants are followed up for 30 days.

Registry
clinicaltrials.gov
Start Date
September 25, 2021
End Date
December 7, 2022
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • African American/Black
  • Body mass index (BMI) \> 25 kg/m\^2
  • Associated with a participating church through membership or participation in a church activity
  • Cleared by a Primary Care Provider (PCP-Doctor) to be a part of the study
  • Not currently on weight loss medications
  • Not pregnant or lactating
  • Has not lost at least 10% of their body weight in the last 6 months
  • Has not had bariatric surgery in the last 10 years
  • Able to walk unassisted and continuously for 10 minutes

Exclusion Criteria

  • Adults unable to consent
  • Adults unable to complete study measures in English
  • Individuals who are not yet adults (infants, children, teenagers)
  • Individuals who are pregnant or lactating
  • Adults who have had a myocardial infarction (heart attack) or stroke without medical clearance from their primary care physician to participate in the study
  • Adults who currently have type 1 or type 2 diabetes without medical clearance from their primary care physician to participate in the study

Outcomes

Primary Outcomes

Change in heart rate

Time Frame: Up to 6 months

Change in blood pressure

Time Frame: AT 6 months

Change in body weight

Time Frame: Up to 6 months

Changes in body composition

Time Frame: up to 6 months

Change in hip circumference

Time Frame: Up to 6 months

Change in height

Time Frame: up to 6 months

Change in waist circumference

Time Frame: Up to t 6 months

Secondary Outcomes

  • Dietary intake(Up to 6 months)
  • glucose metabolism(UP to 6 months)
  • C-Peptide level(Up to 6 months)
  • changes in Adipokine levels(Up to 6 months)
  • Obesity-related biomarker analysis(Up to 6 months)

Study Sites (1)

Loading locations...

Similar Trials